Wolverine Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $522K | Sell |
2,400
-24,600
| -91% | -$5.46M | 0.01% | 923 |
|
|
2025
Q4 | $6.17M | Sell |
27,000
-20,400
| -43% | -$4.65M | 0.05% | 316 |
|
|
2025
Q3 | $11M | Buy |
47,400
+600
| +1% | +$122K | 0.08% | 226 |
|
|
2025
Q2 | $8.69M | Buy |
46,800
+37,100
| +382% | +$6.89M | 0.08% | 244 |
|
|
2025
Q1 | $2.03M | Buy |
9,700
+3,500
| +56% | +$680K | 0.02% | 512 |
|
|
2024
Q4 | $1.1M | Buy |
6,200
+5,700
| +1,140% | +$1.05M | 0.01% | 666 |
|
|
2024
Q3 | $98.7K | Sell |
500
-1,900
| -79% | -$355K | ﹤0.01% | 1111 |
|
|
2024
Q2 | $412K | Sell |
2,400
-10,800
| -82% | -$1.79M | ﹤0.01% | 885 |
|
|
2024
Q1 | $2.4M | Sell |
13,200
-50,400
| -79% | -$8.69M | 0.03% | 447 |
|
|
2023
Q4 | $9.86M | Buy |
63,600
+14,700
| +30% | +$2.14M | 0.08% | 238 |
|
|
2023
Q3 | $7.29M | Sell |
48,900
-6,800
| -12% | -$998K | 0.08% | 255 |
|
|
2023
Q2 | $7.5M | Sell |
55,700
-8,400
| -13% | -$1.23M | 0.09% | 225 |
|
|
2023
Q1 | $10.2M | Sell |
64,100
-23,700
| -27% | -$3.62M | 0.12% | 199 |
|
|
2022
Q4 | $14.2M | Buy |
87,800
+80,100
| +1,040% | +$12.3M | 0.15% | 173 |
|
|
2022
Q3 | $1.03M | Buy |
+7,700
| New | +$1.1M | 0.01% | 772 |
|
|
2018
Q2 | – | Sell |
-10,800
| Closed | -$1.02M | – | 1366 |
|
|
2018
Q1 | $1.02M | Buy |
+10,800
| New | +$1.19M | 0.01% | 757 |
|
|
2017
Q4 | – | Sell |
-500
| Closed | -$44K | – | 1413 |
|
|
2017
Q3 | $44K | Sell |
500
-16,700
| -97% | -$1.27M | ﹤0.01% | 1186 |
|
|
2017
Q2 | $1.25M | Sell |
17,200
-107,800
| -86% | -$7.25M | 0.02% | 561 |
|
|
2017
Q1 | $8.14M | Buy |
+125,000
| New | +$7.86M | 0.13% | 156 |
|
|
2016
Q1 | – | Sell |
-100
| Closed | -$7K | – | 1196 |
|
|
2015
Q4 | $7K | Sell |
100
-30
| -23% | -$1.73K | ﹤0.01% | 1448 |
|
|
2015
Q3 | $14K | Buy |
+130
| New | +$8.46K | ﹤0.01% | 1516 |
|
|
2015
Q1 | – | Sell |
-140
| Closed | -$204K | – | 1792 |
|
|
2014
Q4 | $204K | Sell |
140
-49
| -26% | -$3.09K | ﹤0.01% | 957 |
|
|
2014
Q3 | $153K | Sell |
189
-71
| -27% | -$3.94K | ﹤0.01% | 1167 |
|
|
2014
Q2 | $289K | Buy |
260
+56
| +27% | +$2.94K | 0.01% | 793 |
|
|
2014
Q1 | $185K | Hold |
204
| – | – | ﹤0.01% | 897 |
|
|
2013
Q4 | $214K | Hold |
204
| – | – | ﹤0.01% | 1130 |
|
|
2013
Q3 | $106K | Hold |
204
| – | – | ﹤0.01% | 1430 |
|
|
2013
Q2 | $83K | Buy |
+204
| New | +$8.92K | ﹤0.01% | 1492 |
|
Other funds holding ABBV
VCM
VPM
Wolverine Asset Management's ABBV Position: Q3 2025 in Review
Wolverine Asset Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 21,256 shares — an estimated $4.33M sold.
Wolverine Asset Management first reported a position in ABBV in Q2 2013 and held it in 25 quarters. The position peaked at $7.78M in Q2 2023. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Wolverine Asset Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- Wolverine Asset Management sold 21,256 AbbVie shares in Q3 2025, an estimated $4.33M.
- Wolverine Asset Management first reported a position in AbbVie in Q2 2013 and held it in 25 quarters.
- Wolverine Asset Management's AbbVie position peaked at $7.78M in Q2 2023.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.